Richard H. Scheller is Executive Vice President of Research and Early Development at Genentech, where his role is to see basic research translated into the development of
new treatments for human disease.
Not exact matches
InvivoSciences will continue to contribute to the improvement of
human health by establishing a
new paradigm
for discovering drugs that focus on
diseases with limited
treatment options such as cardiac fibrosis, scleroderma, and lupus in a time - effective manner while remaining safe and cost effective.»
Now, a study published online April 27th, in the Journal of Immunology, confirms that the cytokine GM - CSF (Granulocyte macrophage colony - stimulating factor) likely plays an important role in
human disease and offers a
new explanation
for why the MS
treatment interferon - Beta (INF - β) is often effective at reducing MS attacks.
Scientists want to be able to clone early
human embryos, using cells from patients with various
diseases, so they can study the
diseases in the lab and develop
new treatments for them.
The findings open up
new avenues
for the
treatment of injuries and degenerative
diseases in adult
humans.
German and Canadian scientists have built a three dimensional map of the
human brain to help in the development of
new treatments for neurological disorders like Alzheimer's and Parkinson's
disease.
Her research is both translational and clinical in nature and centers on the
human genetics of healthy skin aging and
diseases related to aging skin, including
new treatments for advanced basal cell skin cancers.
NIH researchers publish the genomes of 178 microbes that call the
human body home — the project could lead to
new treatments for disease
From this research published in Scientific Reports, scientists aim to unravel the causes behind the
disease in zebrafish and therefore provide
new leads
for a
treatment for human LCA.
Now, in a
new study published in the journal Cell, scientists at the Salk Institute
for Biological Studies have discovered that a synthetic form of vitamin D, calcipotriol (a drug already approved by the FDA
for the
treatment of psoriasis), deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential
new therapy
for fibrotic
diseases in
humans.
Still, Firestein notes, the results need to be borne out in
humans before scientists start investigating
new treatments for the
disease.
Scientists working to develop
new treatments for neurodegenerative
diseases have been stymied by the inability to grow
human motor neurons in the lab.
Salk researchers found that a drug already approved by the FDA
for the
treatment of psoriasis deactivates the switch governing the fibrotic response in mouse liver cells, suggesting a potential
new therapy
for fibrotic
diseases in
humans.
These so - called bioreactors, and the mini-brains they foster, should open other
new and valuable windows into
human brain development, brain disorders and drug testing — and perhaps even produce neurons
for treatment of Parkinson's
disease and other disorders, the investigators say.
Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop
new diagnostics and
treatments for human disease.
Our finding of similarity in clinical progression between
human patients and Huntington's
disease monkeys suggests monkeys could become a preclinical, large animal model
for the development of
new treatments.»
Broad Institute of MIT and Harvard was launched in 2004 to improve
human health by using genomics to advance our understanding of the biology and
treatment of
human disease, and to help lay the groundwork
for a
new generation of therapies.
The pigs showed both movement problems and respiratory difficulties common to
human patients, and it is hoped that this model will assist in the creation of
new treatments for Huntington's — a genetically inherited and fatal
disease which affects tens of thousands of people.
They have also compared the mouse and
human genomes, which together are expected to help researchers find genes
for diseases and lead to
new treatments for human illness.
The group's objectives are focused on using neural progenies of
human Pluripotent Stem (hPS) cells to understand and develop
new treatments for Huntington
Disease (HD).
These powerful tools are rapidly changing the way researchers do their work, and providing
new and novel approaches to
treatments for human disease.
This «humanized» mouse is susceptible to
human liver infections and responds to
human drug
treatments, providing a
new way to test novel therapies
for debilitating
human liver
diseases and other
diseases with liver involvement such as malaria.
Stem cell researchers are getting closer to a
new treatment for sickle cell
disease, moving promising laboratory research into
human clinical trials.
Lanner also hopes to learn things that could help scientists who are trying to turn stem cells from
human embryos into
new treatments for diseases.
A
new stem cell
treatment in Australia designed to treat the root cause of Parkinson's
disease has received approval
for human testing.
Gage and Ghosh discuss how
human skin cells induced to return to an immature state («induced pluripotent stem cells» or IPS cells) are revolutionizing our understanding and
treatment of mental and neurodegenerative disorders, such as Parkinson's
disease, as well as leading to
new models of drug development
for all
diseases.
GENYO is the first national centre devoted to genomics that integrates the Public Administration, the University and the biotechnology and pharmaceutical business sector, which would allow the integration of research in all its phases, from the generation of knowledge to its development in clinical and pharmaceutical applications, the development of
new projects and services
for the prevention, diagnosis and
treatment of
diseases associated to
human genetic variability, such a cancer and rare
diseases, diabetes, hypertension or degenerative
diseases, among others.
This
new treatment has a long way to go before
human trials, but it could one day result in better
treatments for the millions of people suffering from heart
disease.
Donations made to the TGen Foundation will be used to fund TGen's research needs
for improving
human health by helping scientists discover
new treatments, therapies and cures
for many
diseases such as autism, melanoma, pancreatic cancer, brain tumors, diabetes and others.
However, every time a pet travels internationally without proper prior veterinary care and
treatment, it is another chance
for diseases that can impact both
human and animal health to establish themselves in a
new area.
The findings may help further understanding of neurodegenerative
diseases and identify
new treatments for both canine and
human sufferers.